Clotrimazole (mucous membrane)

Jump to: navigation, search
Clotrimazole (mucous membrane)
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Overview

Clotrimazole (mucous membrane) is an azole antifungal that is FDA approved for the treatment of tinea pedis, tinea cruris and tinea corporis. Common adverse reactions include nausea and vomiting.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Anti-Fungal

  • Dosing information
  • Clean the affected area and dry thoroughly. Apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor. Supervise children in the use of this product. For athlete's foot: Pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily. For athlete's foot and ringworm, use daily for 4 weeks; for jock itch, use daily for 2 weeks. If condition persists longer, consult a doctor. This product is not effective on the scalp or nails.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

  • There is limited information regarding Off-Label Guideline-Supported Use of clotrimazole in adult patients.

Non–Guideline-Supported Use

Candidal vulvovaginitis

  • Dosing information
  • 0.5 grams administered once weekly for 2 weeks[1]

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

  • There is limited information regarding FDA-Labeled Use of Clotrimazole (mucous membrane) in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

  • There is limited information regarding Off-Label Guideline-Supported Use of clotrimazole in pediatric patients.

Non–Guideline-Supported Use

  • There is limited information regarding Off-Label Non–Guideline-Supported Use of clotrimazole in pediatric patients.

Contraindications

Hypersensitivity to clotrimazole.

Warnings

  • For exteranl use only.
  • If swallowed, get medical help or contact a Poison Control Center right away.
  • Do not use on children under 2 years of age unless directed by a doctor.
  • Avoid contact with the eyes.
  • If irritation occurs or if there is no improvement within 2 weeks, discontinue use and consult a doctor.
  • Keep out of reach of children

Adverse Reactions

Clinical Trials Experience

Postmarketing Experience

  • FDA package insert for clotrimazole contains no information regarding Post marketing experience.

Drug Interactions

There is limited information regarding Clotrimazole (mucous membrane) Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Clotrimazole (mucous membrane) in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Clotrimazole (mucous membrane) in women who are pregnant.

Labor and Delivery

  • There is no FDA guidance on use of Clotrimazole (mucous membrane) during labor and delivery.

Nursing Mothers

  • There is no FDA guidance on the use of Clotrimazole (mucous membrane) with respect to nursing mothers.

Pediatric Use

  • There is no FDA guidance on the use of Clotrimazole (mucous membrane) with respect to pediatric patients.

Geriatic Use

  • There is no FDA guidance on the use of Clotrimazole (mucous membrane) with respect to geriatric patients.

Gender

  • There is no FDA guidance on the use of Clotrimazole (mucous membrane) with respect to specific gender populations.

Race

  • There is no FDA guidance on the use of Clotrimazole (mucous membrane) with respect to specific racial populations.

Renal Impairment

  • There is no FDA guidance on the use of Clotrimazole (mucous membrane) in patients with renal impairment.

Hepatic Impairment

  • There is no FDA guidance on the use of Clotrimazole (mucous membrane) in patients with hepatic impairment.

Females of Reproductive Potential and Males

  • There is no FDA guidance on the use of Clotrimazole (mucous membrane) in women of reproductive potentials and males.

Immunocompromised Patients

  • There is no FDA guidance one the use of Clotrimazole (mucous membrane) in patients who are immunocompromised.

Administration and Monitoring

Administration

  • For exteranl use only.

Monitoring

  • FDA package insert for clotrimazole contains no information regarding drug monitoring.

IV Compatibility

  • There is limited information about the IV compatibility.

Overdosage

There is limited information regarding Clotrimazole (mucous membrane) overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

Clotrimazole.png
Clotrimazole-xtal-3D-balls.png
Clotrimazole (mucous membrane)
Systematic (IUPAC) name
1-[(2-Chlorophenyl)(diphenyl)methyl]-1H-imidazole
Identifiers
CAS number 23593-75-1
ATC code A01AB18 D01AC01 (WHO) G01AF02 (WHO) Template:ATCvet
PubChem 2812
DrugBank DB00257
Chemical data
Formula C22H17ClN2 
Mol. mass 344.837 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability Poor oral absorption (troche), negligible absorption through intact skin (topical)
Protein binding 90%
Metabolism hepatic
Half life 2 hours
Excretion ?
Therapeutic considerations
Pregnancy cat.

A(AU) C (oral) and B (topical) (US)

Legal status

?(US)

Routes topical, troche

Mechanism of Action

There is limited information regarding Clotrimazole (mucous membrane) Mechanism of Action in the drug label.

Structure

There is limited information regarding Clotrimazole (mucous membrane) Structure in the drug label.

Pharmacodynamics

  • There is limited information regarding Pharmacodynamics of Clotrimazole (mucous membrane) in the drug label.

Pharmacokinetics

  • There is limited information regarding Pharmacokinetics of Clotrimazole (mucous membrane) in the drug label.

Nonclinical Toxicology

  • There is limited information regarding Nonclinical Toxicology of Clotrimazole (mucous membrane) in the drug label.

Clinical Studies

  • There is limited information regarding Clinical Studies of Clotrimazole (mucous membrane) in the drug label.

How Supplied

There is limited information regarding Clotrimazole (mucous membrane) How Supplied in the drug label.

Storage

There is limited information regarding Clotrimazole (mucous membrane) Storage in the drug label.

Images

Drug Images

Package and Label Display Panel

Clotrimazole label 01.jpg
This image of the FDA label is provided by the National Library of Medicine.

Patient Counseling Information

  • There is limited information regarding Patient Counseling Information of Clotrimazole (mucous membrane) in the drug label.

Precautions with Alcohol

  • Alcohol-Clotrimazole interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

3 Day Vaginal Cream Clotrim Antifungal Cruex Prescription Strength Gyne-Lotrimin Gyne-Lotrimin 3 Lotrimin Lotrimin AF Mycelex

Look-Alike Drug Names

There is limited information regarding Clotrimazole (mucous membrane) Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. Sobel JD, Schmitt C, Meriwether C (1989). "Clotrimazole treatment of recurrent and chronic candida vulvovaginitis". Obstet Gynecol. 73 (3 Pt 1): 330–4. PMID 2644595.

Linked-in.jpg